Mohamed Azab
- Surgery top 10%
- Pathology and Forensic Medicine top 10%
- Oncology
- Pediatrics, Perinatology and Child Health top 10%
- Public Health, Environmental and Occupational Health
- Co-authors
- Suzy SchollP PouillartBernard PauleJ BonsJean Pierre DrozÉric Pujade-LauraineMichel MartyChristine Théodore
- Topics
- Testicular diseases and treatments (4 papers)Gestational Trophoblastic Disease Studies (3 papers)Neuroblastoma Research and Treatments (3 papers)
- Partner nations
- FranceUnited StatesEgypt
In The Last Decade
Mohamed Azab
29 papers receiving 722 citations
Peers
Comparison fields: 5 of 84
- Surgery 358
- Pathology and Forensic Medicine 167
- Oncology 146
- Pediatrics, Perinatology and Child Health 131
- Public Health, Environmental and Occupational Health 114
Countries citing papers authored by Mohamed Azab
This map shows the geographic impact of Mohamed Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Azab more than expected).
Fields of papers citing papers by Mohamed Azab
This network shows the impact of papers produced by Mohamed Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Azab. The network helps show where Mohamed Azab may publish in the future.
Co-authorship network of co-authors of Mohamed Azab
This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Azab. A scholar is included among the top collaborators of Mohamed Azab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Azab. Mohamed Azab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 21 | |
| 5 | 7 | |
| 6 | 5 | |
| 7 | 19 | |
| 8 | 25 | |
| 9 | 9 | |
| 10 | 14 | |
| 11 | 43 | |
| 12 | 4 | |
| 13 | 10 | |
| 14 | 328 | |
| 15 | 11 | |
| 16 | 1 | |
| 17 | 33 | |
| 18 | Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors. | 3 |
| 19 | [A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin]. | 1 |
| 20 | 29 |
About Mohamed Azab
Mohamed Azab is a scholar working on Equine, Gastroenterology and Emergency Medicine, having authored 33 papers that have together received 757 indexed citations. Recurring topics across this work include Testicular diseases and treatments (4 papers), Gestational Trophoblastic Disease Studies (3 papers) and Neuroblastoma Research and Treatments (3 papers). The work is most often cited by research in Gastroenterology (73 citations), Pathology and Forensic Medicine (167 citations) and Surgery (358 citations). Mohamed Azab has collaborated with scholars based in France, United States and Egypt. Frequent co-authors include Suzy Scholl, P Pouillart, Bernard Paule, J Bons, Jean Pierre Droz, Éric Pujade-Lauraine, Michel Marty, Christine Théodore, Jean‐Pierre Droz and Philippe Rougier. Their work appears in journals such as New England Journal of Medicine, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.